Xl-Dol

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including the common cold, headaches, toothaches, muscular aches, and minor pain from arthritis. Additionally, it is effective in reducing fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and over are instructed to take 1 to 2 tablets orally every 4 to 6 hours as needed. The maximum dosage should not exceed 8 tablets within a 24-hour period unless otherwise directed by a healthcare professional. For children under 12 years of age, it is essential to consult a doctor prior to administration.

Contraindications

Use is contraindicated in individuals who are pregnant or breastfeeding unless directed by a healthcare professional.

Warnings and Precautions

The use of this product necessitates careful adherence to specific warnings and precautions to ensure patient safety and efficacy.

Warnings

This product must not be used in conjunction with any other product containing acetaminophen. It is imperative that the duration of use does not exceed 10 days for pain relief or 3 days for fever, unless directed by a healthcare professional.

General Precautions

To ensure safety, this product should be kept out of the reach of children. In the event of an overdose, immediate medical assistance should be sought, or a Poison Control Center should be contacted without delay. Prompt medical attention is crucial for both adults and children, even if no signs or symptoms are initially apparent. Pregnant or breastfeeding individuals should consult a healthcare professional prior to use.

Stop Taking and Call Your Doctor

Patients should discontinue use and consult a physician if any of the following occur: symptoms do not improve, new symptoms arise, pain or fever persists or worsens, or if there is any redness or swelling present.

Get Emergency Medical Help

In the case of an overdose, it is essential to seek emergency medical help or contact a Poison Control Center immediately.

Side Effects

Patients should be aware of the following adverse reactions associated with the use of this product. It is important to note that the product should not be used in conjunction with any other product containing acetaminophen. Additionally, it is advised that the product not be used for more than 10 days for pain or more than 3 days for fever unless directed by a healthcare professional.

In the event that symptoms do not improve, new symptoms occur, or if pain or fever persists or worsens, patients should discontinue use of the product and consult a doctor. Furthermore, the presence of redness or swelling should prompt immediate medical attention. These precautions are essential to ensure patient safety and to mitigate the risk of serious adverse reactions.

Drug Interactions

Acetaminophen should not be used concurrently with any other products containing acetaminophen due to the risk of overdose and potential liver damage.

Patients who consume three or more alcoholic beverages daily are advised to consult their healthcare provider regarding the use of acetaminophen or other pain relievers and fever reducers. Chronic alcohol consumption can increase the risk of hepatotoxicity associated with acetaminophen use.

No specific laboratory test interactions have been identified in the available data.

Packaging & NDC

Below are the non-prescription pack sizes of Xl-Dol (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a doctor before use. For adolescents aged 12 years and older, the recommended dosage is 1 to 2 tablets every 4 to 6 hours as needed, with a maximum of 8 tablets in a 24-hour period unless otherwise directed by a healthcare professional.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to evaluate the potential risks and benefits associated with the use of this drug during pregnancy and lactation. Healthcare providers should consider the available data and individual patient circumstances when advising on the use of this medication in these populations.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider individual patient factors when prescribing to patients with renal impairment, as the absence of detailed guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of the reach of children to prevent accidental ingestion.

In the event of an overdose, it is crucial for patients to seek medical help or contact a Poison Control Center immediately. Prompt medical attention is essential for both adults and children, even if no signs or symptoms are apparent.

Patients who are pregnant or breastfeeding should be encouraged to consult a healthcare professional before using this medication to ensure safety for themselves and their child.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, specifically within the range of 20°C to 25°C (68°F to 77°F). It is essential to protect the product from light exposure to prevent degradation. Additionally, the product should be kept out of reach of children, and any unused portion should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

The medication is administered orally, with the recommended dosage for adults and children aged 12 years and older being 1 to 2 tablets every 4 to 6 hours as needed, not exceeding 8 tablets in a 24-hour period unless directed by a physician. For children under 12 years of age, consultation with a doctor is advised.

Clinicians should counsel patients regarding the use of the medication during pregnancy or breastfeeding, recommending that they consult a health professional before use. Additionally, patients who consume three or more alcoholic drinks daily should seek medical advice before taking acetaminophen or other pain relievers/fever reducers, as acetaminophen has the potential to cause liver damage.

Drug Information (PDF)

This file contains official product information for Xl-Dol, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)